Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.

Clinical trial NCT06947473 · RECRUITING

Trial details

NCT number: NCT06947473
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Lupus Nephritis Systemic Sclerosis Primary Sjogren's Syndrome Combined With Pulmonary Hypertension

Start date: 2026-03-18
Primary completion: 2026-07-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.